Drug Reference

raloxifene
Class: Hormonal therapy Generic Name: Raloxifene (reh-LOCKS-eh-feen) Trade Name: Evista® For which conditions is this drug approved? Raloxifene is FDA approved for the prevention and treatment of osteoporosis in postmenopausal women. It is important for patients to remember that physicians have the ability to prescribe medication for conditions other than those ... Read More...

rasburicase
Class: Supportive care Generic Name: Rasburicase Trade Name: Elitek® How is this drug used? Rasburicase is FDA approved for the management of uric acid levels in pediatric patients with leukemia, lymphoma and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis syndrome and subsequent elevation of ... Read More...

recombinant human interleukin 2
Class: Biologic therapy Generic Name: Aldesleukin (al-des-LOO-kin), Interleukin-2, recombinant human interleukin 2, IL-2 Trade Name: Proleukin® For which conditions is this drug approved? Aldesleukin is currently FDA approved for the treatment of metastatic melanoma and metastatic renal cell carcinoma. It is important for patients to remember that physicians have the ability to prescribe medication for conditions other ... Read More...

Revlimid
Class: Biologic Therapy Generic Name: Lenalidomide (len-a-LID-oh-mide) Trade Name: Revlimid® For which conditions is this drug approved? Lenalidomide is FDA approved for the treatment of low or intermediate-1-risk myelodysplastic syndromes in patients who are transfusion-dependent because of anemia associated with their disease and those who have a deletion 5q cytogenetic abnormality. Lenalidomide is ... Read More...

Rheumatrex
Class: Chemotherapy Generic Name: Methotrexate (meth-oh-TRECKS-ate), Amethopterin, Methotrexate Sodium, MTX Trade Name: Rheumatrex®, TrexallTM How is this drug used? Methotrexate is FDA approved for the following cancers: gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole, acute lymphocytic leukemia, meningeal leukemia, breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides, ... Read More...

Rituxan
Class: Biologic therapy Generic Name: Rituximab (ri-TUCKS-I-mab) Trade Name: Rituxan® How is this drug used? Rituximab is FDA approved for the treatment ofsome types of CD20+, B-cell non-Hodgkin’s lymphoma (NHL). It is important for patients to remember that physicians have the ability to prescribe medication for conditions other than those for which ... Read More...

rituximab
Class: Biologic therapy Generic Name: Rituximab (ri-TUCKS-I-mab) Trade Name: Rituxan® How is this drug used? Rituximab is FDA approved for the treatment of some types of CD20+, B-cell non-Hodgkin’s lymphoma (NHL). It is important for patients to remember that physicians have the ability to prescribe medication for conditions other than those for which ... Read More...

Roferon-A
Class: Biologic response modifier Generic Name: Interferon alpha (in-ter-FEER-on), alpha interferon, IFN-alpha Trade Name: Intron® A (interferon alfa-2b), Roferon-A® (interferon alfa-2a) How is this drug used? Interferon alpha is FDA approved for the treatment of hairy cell leukemia, malignant melanoma, AIDS-related Kaposi’s sarcoma, follicular non-Hodgkin’s lymphoma, and Condylomata Acuminata. It is important ... Read More...

Rubex
Class: Chemotherapy Generic Name: Doxorubicin (docks-oh-ROO-bi-sin) Trade Name: Adriamycin®, Rubex® For which conditions is this drug approved? Doxorubicin is used for the treatment of several cancers, including bladder, breast, head and neck, leukemia, liver, lung, lymphomas, mesothelioma, multiple myeloma, neuroblastoma, ovary, pancreas, prostate, sarcomas, stomach, testis (germ cell), thyroid, and uterus. ... Read More...

rubidomycin hydrochloride
Class: Chemotherapy Generic Name: Daunorubicin (don-ah-ROO-bi-sin), daunorubicin hydrochloride, daunomycin, rubidomycin hydrochloride Trade Name: Cerubidine® For which conditions is this drug approved? Daunorubicin is FDA approved in combination with other anticancer agents for the treatment of acute myelogenous leukemia and acute lymphocytic leukemia. It is important for patients to remember that physicians ... Read More...